AVLN (AVLN) Stock Price & Analysis
AVLN (AVLN) rose 5.50% to USD 37.39 as of September 8, 2026 at 08:22 UTC, according to Nexqual real-time market data.
AVLN last closed at USD 37.39; the session ranged USD 34.99–38.34 on volume of 243,509 shares. Market capitalization is —, with a 52-week range of USD 24.15–40.17 (NMS). Source: Nexqual, September 8, 2026 at 08:22 UTC.
Key Statistics (as of September 8, 2026 at 08:22 UTC)
| Price | USD 37.39 |
|---|---|
| Change | ▲ 5.50% (up) |
| Previous Close | USD 37.39 |
| Open | USD 37.39 |
| Day Range | USD 34.99 – 38.34 |
| 52-Week Range | USD 24.15 – 40.17 |
| Volume | 243,509 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (AVLN)
Nexqual's technical model rates AVLN "STRONG BUY" based on 5 bullish and 0 bearish signals across 89 daily candles, as of September 8, 2026 at 08:22 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 60.57 (neutral) |
| vs SMA50 | Above (USD 32.3) |
| MACD | 1.02 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| COAG | Hemab Therapeutics Holdings, In | USD 44.41 | ▼ 0.65% |
| SPTX | Seaport Therapeutics, Inc. | USD 24.86 | ▼ 0.2% |
| KLRA | Kailera Therapeutics, Inc. | USD 16.23 | ▲ 2.4% |
| ODTX | Odyssey Therapeutics, Inc. | USD 28.76 | ▲ 8.04% |
| EIKN | Eikon Therapeutics, Inc. | USD 10.86 | ▼ 4.57% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 08:22 UTC. This page is informational and not investment advice.